Jazz Pharmaceuticals plc

Filed a patent for "methods of use of a liposomal composition comprising an atr inhibitor" on Fri, July 14, 2023

Filed a patent for "combinations comprising an atr inhibitor and a parp inhibitor and methods of use thereof" on Fri, July 14, 2023

Filed a patent for "methods of treating solid tumors with mitogen activated protein kinase (mapk) pathway alterations" on Fri, February 17, 2023

Filed a patent for "interferon prodrugs" on Tue, March 14, 2023

Filed a patent for "interferon prodrugs" on Mon, April 3, 2023

Filed a patent for "oral solid dosage forms comprising cannabinoids" on Thu, October 3, 2024

Filed a patent for "method of administering oxybate" on Mon, April 8, 2024

Filed a patent for "ghb dosing" on Thu, August 29, 2024

Filed a patent for "6-hydroxy-cannabidiol-c4" on Fri, November 10, 2023

Filed a patent for "use of cannabidiol in the treatment of nocturnal snoring" on Thu, August 8, 2024

Filed a patent for "treatment of hematological disorders" on Thu, August 1, 2024

Filed a patent for "methods for preparing liposomal formulations" on Tue, January 16, 2024

Filed a patent for "cannabidiol preparations and its uses" on Thu, June 27, 2024

Filed a patent for "method of treating posttraumatic stress disorder" on Wed, January 31, 2024

Filed a patent for "use of cannabidiol in the treatment of epilepsy" on Thu, October 13, 2022

Filed a patent for "gamma-hydroxybutyrate compositions and their use for the treatment of disorders" on Thu, November 17, 2022

Filed a patent for "method of lyophilizing liposomes" on Thu, June 8, 2023

Filed a patent for "liposomal formulations of bcl inhibitors" on Thu, February 23, 2023

Filed a patent for "methods for treating patients having sinusoidal obstruction syndrome" on Thu, March 16, 2023

Filed a patent for "defibrotide for use in preventing and treating sepsis" on Tue, October 25, 2022

Filed a patent for "defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion" on Thu, June 22, 2023

Filed a patent for "use of cannabidiol in the treatment of epilepsy" on Thu, July 20, 2023

Filed a patent for "approach for treatment of cancer via immunomodulation by using talabostat" on Thu, January 4, 2024

Filed a patent for "use of cannabidiol in the treatment of seizures associated with mutations in the syngapi gene" on Thu, September 14, 2023

Filed a patent for "use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities" on Thu, October 5, 2023